U.S. Presidential Candidate Bernie Sanders Announces Plan To Lower HIV Drug Prices, Spur Development Of New Drugs

Gay Times: Bernie Sanders announces plan for an ‘AIDS-free generation’
“The Democrat’s campaign released a statement on his website claiming that one of the ‘biggest problems’ in the U.S. is allowing access to affordable drugs for HIV-positive people…” (Megarry, 3/15).

The Hill: Sanders releases plan to lower AIDS drug prices
“Bernie Sanders on Monday released a plan aimed at making HIV/AIDS drugs more affordable, part of a larger effort aimed at bringing down prescription prices. Sanders’s plan would be a major shake-up of the current drug system. … The goal is to bring down prices while still providing an incentive for companies to innovate…” (Sullivan, 3/14).

Wall Street Journal: Bernie Sanders to Unveil HIV/AIDS Research Initiative
“…[Sen. Bernie] Sanders, who is advocating a single-payer health system, will propose establishing a $3 billion annual fund to reward developers who come up with new treatments for HIV and AIDS. The candidate for the Democratic presidential nomination wants to award money from the HIV/AIDS prize fund and permit generic competition for the newly developed drugs immediately after they are approved by the Food and Drug Administration…” (Armour, 3/14).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.